SubscribeOur New Pick - MVSR
I believe the market took it's toll on Medivisor (MVSR) last week, bringing it down to a price that is a great entry point. Currently at $ 0.30, this stock is poised for a nice upward move.
The big news on this one is that they have a contract to sell a recently FDA approved oral gel (Mucotrol) which helps in the treatment of mouth sores related to chemotherapy and radiation.
A recent profile on MVSR reported the following...
Quote From Report...
As an exclusive Mucotrol drug partner, MVSR is a virtual cash machine,
operating from a position of strength while capturing huge growth in the dominant pharmaceutical industry.
MVSR has built an enterprising foundation which is on track to fulfill an enormous return on a revenue
base that parallels the historical growth of FORTUNE 500 pharmaceutical leaders in their heyday.
The report goes on to highlight how MVSR has recently made exclusive deals with Cura Pharmaceutical for it MVSR's product Mucotrol. The deal is said to have brought about billions in possible sales.
The report also quotes that MVSR has been targetted for a $5.00/share takeover possibility! While I'm probably looking for a target of $1 in the short run, that's still a huge jump.
We currently have no position on MVSR but are looking to get in on Monday's open.
Be sure to take a look at their site: http://www.medivisor.com/
Penny Stocks Finder
The big news on this one is that they have a contract to sell a recently FDA approved oral gel (Mucotrol) which helps in the treatment of mouth sores related to chemotherapy and radiation.
A recent profile on MVSR reported the following...
Quote From Report...
As an exclusive Mucotrol drug partner, MVSR is a virtual cash machine,
operating from a position of strength while capturing huge growth in the dominant pharmaceutical industry.
MVSR has built an enterprising foundation which is on track to fulfill an enormous return on a revenue
base that parallels the historical growth of FORTUNE 500 pharmaceutical leaders in their heyday.
The report goes on to highlight how MVSR has recently made exclusive deals with Cura Pharmaceutical for it MVSR's product Mucotrol. The deal is said to have brought about billions in possible sales.
The report also quotes that MVSR has been targetted for a $5.00/share takeover possibility! While I'm probably looking for a target of $1 in the short run, that's still a huge jump.
We currently have no position on MVSR but are looking to get in on Monday's open.
Be sure to take a look at their site: http://www.medivisor.com/
Penny Stocks Finder